These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8808181)

  • 1. Evaluation of different doses of formoterol from a newly developed powder inhalation device in asthmatic patients.
    van den Berg BT; Smeets JJ; van Boxtel CJ; Maesen FP
    Fundam Clin Pharmacol; 1995; 9(6):593-603. PubMed ID: 8808181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
    Wallin A; Sandström T; Rosenhall L; Melander B
    Thorax; 1993 Jun; 48(6):611-4. PubMed ID: 8346490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
    Cazzola M; D'Amato M; Califano C; Di Perna F; Calderaro E; Matera MG; D'Amato G
    Clin Ther; 2002 Apr; 24(4):595-604. PubMed ID: 12017404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
    Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
    Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
    Lebecque P; Vliers S; De Saint-Moulin T; Godding V
    Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formoterol as dry powder inhalation. A dose finding study in comparison with formoterol metered dose inhaler and placebo.
    Maesen FP; Costongs R; Smeets SJ; Zweers PG; Goedhart DM
    Chest; 1992 May; 101(5):1376-81. PubMed ID: 1582300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial.
    Pleskow W; LaForce CF; Yegen U; Matos D; Della Cioppa G
    J Asthma; 2003; 40(5):505-14. PubMed ID: 14529100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler.
    Lötvall J; Mellén A; Arvidsson P; Palmqvist M; Radielovic P; Kottakis J; Pfister P
    Can Respir J; 1999; 6(5):412-6. PubMed ID: 10572207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
    van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR
    Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma.
    Dahl R; Creemers JP; Van Noord J; Sips A; Della Cioppa G; Thomson M; Andriano K; Kottakis J; Fashola T
    Respiration; 2004; 71(2):126-33. PubMed ID: 15031566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler.
    Ringdal N; Derom E; Wåhlin-Boll E; Pauwels R
    Respir Med; 1998 Aug; 92(8):1017-21. PubMed ID: 9893769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of formoterol in elderly patients with reversible obstructive airways disease.
    Thomson NC; Angus R; Quebe-Fehling E; Brambilla R
    Respir Med; 1998 Mar; 92(3):562-7. PubMed ID: 9692123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations.
    Maesen FP; Costongs R; Smeets JJ; Brombacher PJ; Zweers PG
    Chest; 1991 Jun; 99(6):1367-73. PubMed ID: 2036817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective and subjective bronchodilation over 12 hours after inhaled formoterol: individual responses.
    Arvidsson P; Larsson S; Löfdahl CG
    J Asthma; 1993; 30(6):459-65. PubMed ID: 8244916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
    Löfdahl CG; Svedmyr N
    Allergy; 1989 May; 44(4):264-71. PubMed ID: 2544117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The duration of action of inhaled formoterol dry powder.
    Quebe-Fehling E; Brambilla R; Bromly CL; Fishwick K; Walters EH; Hendrick DJ
    Br J Clin Pract; 1996 Dec; 50(8):446-9. PubMed ID: 9039716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.